Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$7.94 -0.13 (-1.61%)
At close: Oct 20, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Acquisitions (2026)

Updated

Biocryst Pharmaceuticals' Acquisitions was $489.48 million in Q1 2026.

Analysis

Biocryst Pharmaceuticals (BCRX) Acquisitions (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Biocryst Pharmaceuticals 2.02 Bn 940.71 Mn 214.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 489.48 Mn
API Access

Biocryst Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=BCRX&period=max&api_key=YOUR_API_KEY